H3-4
Basic information
Region (hg38): 1:228424845-228425360
Previous symbols: [ "H3FT", "HIST3H3" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the H3-4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 28 | 28 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 28 | 1 | 0 |
Variants in H3-4
This is a list of pathogenic ClinVar variants found in the H3-4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-228424923-G-A | not specified | Uncertain significance (Apr 06, 2023) | ||
1-228424929-C-T | not specified | Uncertain significance (Jan 14, 2025) | ||
1-228424960-A-G | Likely benign (Sep 01, 2022) | |||
1-228424977-G-A | not specified | Uncertain significance (Aug 23, 2021) | ||
1-228425019-C-T | not specified | Uncertain significance (Dec 10, 2024) | ||
1-228425037-A-T | not specified | Uncertain significance (Jun 24, 2022) | ||
1-228425094-C-T | not specified | Uncertain significance (Nov 26, 2024) | ||
1-228425097-G-C | not specified | Uncertain significance (Dec 05, 2024) | ||
1-228425102-A-T | not specified | Uncertain significance (Apr 12, 2022) | ||
1-228425109-G-C | not specified | Uncertain significance (Jan 17, 2024) | ||
1-228425111-A-G | not specified | Uncertain significance (Jan 09, 2024) | ||
1-228425112-T-C | not specified | Likely benign (Feb 10, 2025) | ||
1-228425136-G-C | not specified | Uncertain significance (May 10, 2024) | ||
1-228425165-C-T | not specified | Uncertain significance (May 09, 2023) | ||
1-228425168-C-T | not specified | Uncertain significance (Mar 20, 2024) | ||
1-228425169-G-T | not specified | Uncertain significance (Aug 16, 2022) | ||
1-228425183-G-A | not specified | Uncertain significance (Jan 21, 2025) | ||
1-228425195-G-C | not specified | Uncertain significance (Dec 28, 2023) | ||
1-228425201-T-C | not specified | Uncertain significance (May 03, 2023) | ||
1-228425205-G-A | not specified | Uncertain significance (Oct 08, 2024) | ||
1-228425208-G-A | not specified | Uncertain significance (Mar 07, 2025) | ||
1-228425212-C-G | not specified | Uncertain significance (Dec 25, 2024) | ||
1-228425219-A-G | not specified | Uncertain significance (Mar 15, 2024) | ||
1-228425223-C-T | not specified | Uncertain significance (Oct 16, 2024) | ||
1-228425231-G-T | not specified | Uncertain significance (Nov 08, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
H3-4 | protein_coding | protein_coding | ENST00000366696 | 1 | 481 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000165 | 0.144 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -2.00 | 163 | 105 | 1.55 | 0.00000968 | 857 |
Missense in Polyphen | 55 | 31.401 | 1.7515 | 303 | ||
Synonymous | -4.13 | 80 | 44.8 | 1.79 | 0.00000383 | 305 |
Loss of Function | -1.08 | 6 | 3.75 | 1.60 | 2.49e-7 | 36 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.;
- Pathway
- Systemic lupus erythematosus - Homo sapiens (human);Transcriptional misregulation in cancer - Homo sapiens (human);Alcoholism - Homo sapiens (human);Follicle Stimulating Hormone (FSH) signaling pathway;HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);DNA Repair;Signaling by WNT;Signal Transduction;Nonhomologous End-Joining (NHEJ);DNA Double-Strand Break Repair;Homology Directed Repair;Reproduction;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;Meiotic synapsis;Meiosis;Packaging Of Telomere Ends;Telomere Maintenance;Chromosome Maintenance;EGFR1;Condensation of Prophase Chromosomes;Mitotic Prophase;IL4;M Phase;Cell Cycle;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;DNA Double Strand Break Response;Cell Cycle, Mitotic;Processing of DNA double-strand break ends;Formation of the beta-catenin:TCF transactivating complex;TCF dependent signaling in response to WNT
(Consensus)
Recessive Scores
- pRec
- 0.122
Intolerance Scores
- loftool
- 0.643
- rvis_EVS
- -0.51
- rvis_percentile_EVS
- 21.41
Haploinsufficiency Scores
- pHI
- 0.602
- hipred
- Y
- hipred_score
- 0.595
- ghis
- 0.454
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.601
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- double-strand break repair via nonhomologous end joining;nucleosome assembly;telomere capping;negative regulation of protein oligomerization;protein heterotetramerization
- Cellular component
- nuclear chromosome, telomeric region;nucleosome;nuclear nucleosome;nucleus;nucleoplasm;extracellular exosome
- Molecular function
- protein binding;nucleosomal DNA binding;protein heterodimerization activity